GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » 3-Year Revenue Growth Rate

CBIH (Cannabis Bioscience International Holdings) 3-Year Revenue Growth Rate : 0.00% (As of Nov. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings 3-Year Revenue Growth Rate?

Cannabis Bioscience International Holdings's Revenue per Share for the three months ended in Nov. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Cannabis Bioscience International Holdings was 400.10% per year. The lowest was 400.10% per year. And the median was 400.10% per year.


Competitive Comparison of Cannabis Bioscience International Holdings's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's 3-Year Revenue Growth Rate falls into.


;
;

Cannabis Bioscience International Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Cannabis Bioscience International Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 435N, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The company provides services in therapeutic areas of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. It offered concierge medicine at an affordable price through a membership-based model through its wholly-owned subsidiary.

Cannabis Bioscience International Holdings Headlines

From GuruFocus

CHNC Completes Review of Its First Three Fiscal Quarters

By PurpleRose PurpleRose 07-12-2022

CHNC Saga, Metamorphosis, and Transformation

By Marketwired Marketwired 02-05-2021